An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Back

ESC Professional Premium Access

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Session: Innovations in public health and health economics (1)

Topic: Health Economics

Speaker: Professor A. Goette (Paderborn, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)

42 presentations

0 follower

4 more presentations in this session

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

Speaker: Doctor J. Chung (Goyang, KR)

Quantity and quality of shared decision making incorporation across major international cardiology guidelines

Speaker: Doctor B. MacDonald (Vancouver, CA)

Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries

Speaker: Doctor M. Walli-Attaei (Oxford, GB)

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Speaker: Mr A. Holt (Copenhagen, DK) Miss J. Liang (Auckland, NZ)

Access the full session

Innovations in public health and health economics (1)

Speakers: Professor A. Goette, Doctor J. Chung, Doctor B. MacDonald, Doctor M. Walli-Attaei, Mr A. Holt...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources